BioCina
Jason Arcediano is an accomplished executive with extensive experience in the biopharmaceutical industry, currently serving as Chief Commercial Officer at BioCina since February 2025. Previous roles include Chief Business Officer at Multiply Labs, where responsibilities encompassed fundraising and strategic partnerships, and Senior Vice President of Business Development at AGC Biologics, where Jason successfully restructured business development operations to achieve record sales. Additional experience includes leadership positions at Rentschler Bio-Pharma, Thermo Fisher, Lonza, Dow Chemical, Miltenyi Biotec, Serologicals/Intergen, and InnoGenex, each contributing to a robust track record in commercial strategy, market expansion, and team leadership. Jason holds a degree in NeuroScience and Immunology with a focus on AIDS Vaccine Development from UC San Diego.
This person is not in any teams
This person is not in any offices
BioCina
BioCina is a global end-to-end biologics Contract Development and Manufacturing Organisation (CDMO), offering highest-quality, cost-effective cell line, process, analytical and formulation development, and cGMP clinical & commercial manufacturing for the microbial, pDNA and mRNA modalities. BioCina’s first facility in Adelaide, South Australia is a testament to the quality of its work. It has a rich history of developing and manufacturing both clinical and commercial drug substance, backed by most critical SME’s having an average tenure of 15+ years at the site. BioCina boasts an elite quality record having successfully passed regulatory inspections by the US FDA, EMA and Health Canada. It is licensed by the Australian TGA for cGMP manufacturing of bulk drug substance or active intermediates. Through a partnership with NovaCina, BioCina offers clients a highest-quality fill-and-finish solution. BioCina is proud to have clients globally, including U.S., Europe, and the Asia Pacific. Because BioCina is not a drug developer, it only serves clients' products. As one of the fastest growing companies in the biopharmaceutical industry across Australia, BioCina was awarded the 2024 South Australia “Emerging Business of the Year” award. Learn more at https://biocina.com.